Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the clinical relevance of Lehmann TNBC subtypes by identifying any differences in response to neoa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Santonja, Angela, Sánchez-Muñoz, Alfonso, Lluch, Ana, Chica-Parrado, Maria Rosario, Albanell, Joan, Chacón, José Ignacio, Antolín, Silvia, Jerez, José Manuel, de la Haba, Juan, de Luque, Vanessa, Fernández-De Sousa, Cristina Elisabeth, Vicioso, Luis, Plata, Yéssica, Ramírez-Tortosa, César Luis, Álvarez, Martina, Llácer, Casilda, Zarcos-Pedrinaci, Irene, Carrasco, Eva, Caballero, Rosalía, Martín, Miguel, Alba, Emilio
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995183/
https://ncbi.nlm.nih.gov/pubmed/29899867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25413
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items